About Tesamorelin
Tesamorelin is a synthetic growth hormone releasing hormone (GHRH) analogue that demonstrates selective activity at GHRH receptors in preclinical research models. This 44-amino acid peptide represents a modified version of human GHRH(1-44) with enhanced stability characteristics for laboratory investigation. Researchers at Stroid UK Shop utilise this compound to examine pituitary-hypothalamic axis function and growth hormone secretion mechanisms. The Beligas formulation provides consistent 2mg dosing for controlled experimental protocols examining GHRH receptor pharmacology and downstream signalling pathways.
Research Applications
Scientific studies investigate tesamorelin’s role in stimulating endogenous growth hormone release through specific GHRH receptor binding. Laboratory research examines this compound’s effects on IGF-1 production, metabolic regulation pathways, and body composition parameters in various experimental models. Researchers studying growth hormone mechanisms analyse tesamorelin’s selectivity profile and duration of action compared to native GHRH sequences. Current investigations focus on lipodystrophy research, metabolic dysfunction models, and age-related growth hormone deficiency studies. Scientists also examine potential applications in cachexia research and muscle wasting condition models. The compound’s stability profile makes it suitable for extended experimental protocols requiring consistent GHRH receptor stimulation. Comparative studies with other research compounds help elucidate growth hormone axis regulation mechanisms. Additionally, researchers investigate tesamorelin’s interaction with various peptide modulators in complex experimental designs.
Technical Specifications
| Compound Name | Tesamorelin |
|---|---|
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Molecular Weight | Verify with supplier |
| Dosage Form | 2mg lyophilised powder |
| Manufacturer | Beligas |
| Storage Conditions | -20°C, protected from light |
| Reconstitution | Bacteriostatic water recommended |
Laboratory Compliance
This tesamorelin preparation is manufactured strictly for in-vitro research purposes and laboratory analysis only. The compound is not intended for human consumption, clinical application, or therapeutic use. Researchers must ensure appropriate institutional approval and safety protocols when conducting studies with this GHRH analogue. All experimental work should follow established laboratory guidelines for peptide handling and storage. This product is supplied for qualified research institutions and licenced laboratories conducting legitimate scientific investigations into growth hormone releasing mechanisms and related physiological pathways.
